The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Harvard Bioscience Inc

Nasdaq: HBIO
Last

(U.S.) $2.60

Today's change0.00 0.00%
Updated August 26 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Harvard Bioscience Inc

Nasdaq: HBIO
Last

(U.S.) $2.60

Today's change0.00 0.00%
Updated August 26 4:00 PM -4GMT. Delayed by at least 15 minutes.

Harvard Bioscience Inc closed at (U.S.)$2.60.

Over the last five days, shares have lost 0.76% and are down 25.07% for the last year to date. This security has underperformed the S&P 500 by 54.76% during the last year.

Key company metrics

  • Open(U.S.) $2.69
  • Previous close(U.S.) $2.60
  • High(U.S.) $2.72
  • Low(U.S.) $2.58
  • Bid / Ask(U.S.) $2.58 / (U.S.) $4.98
  • YTD % change-25.07%
  • Volume90,030
  • Average volume (10-day)132,263
  • Average volume (1-month)98,179
  • Average volume (3-month)135,378
  • 52-week range(U.S.) $2.41 to (U.S.) $4.70
  • Beta1.02
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward16.25×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.57
Updated August 26 4:00 PM -4GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue26272826
Total other revenue--------
Total revenue26272826
Gross profit12131312
Total cost of revenue14141514
Total operating expense27272827
Selling / general / administrative10111010
Research & development2121
Depreciation / amortization1111
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income-100-1
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-100-1
Income after tax-1-1-17-1
Income tax, total00170
Net income-1-1-17-1
Total adjustments to net income--------
Net income before extra. items-1-1-17-1
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-1-17-1
Inc. avail. to common incl. extra. items-1-1-17-1
Diluted net income-1-1-17-1
Dilution adjustment------0
Diluted weighted average shares34343434
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.02-0.50-0.02
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.02-0.02-0.50-0.02